Back to Authors

Johnson, Mallory O.

https://orcid.org/0000-0003-0480-2804

Mayo Clinic

University of California, San Francisco

Citations 2

Complex dynamics between internalized HIV stigma, depression, and anxiety with panic among people with HIV
Crane, H M, Fredericksen, Rob J. , Whitney, Bridget M. , Cachay, Edward, Mayer, Kenneth H., Christopoulos, Katerina, Moore, R, Keruly, Jeanne , Chander, Geetanjali , Johnson, Mallory O. , Saag, Michael S., Crawford, Timothy, Falade, Oluwaseun, Kitahata, Mari M., Bamford, Laura, Yendewa, George A , Delaney, J A C, Drumright, Lydia N. , Crane, Heidi M. , Cachay, Edward R. , Mayer, Kenneth Hugh , Christopoulos, Katerina A. , Napravnik, Sonia , Saag, Michael S. , Neilands, Torsten B. , Crawford, Timothy, Kitahata, Mari M. , Yendewa, George A. , Delaney, Joseph A. , Frost, Simon D. W.

AIDS | April 21, 2026 | Volume: 40 | Issue: 9 | Pages: 1355-1364

10.1097/qad.0000000000004525 Get It

Background: Previous studies suggest that internalized HIV stigma (IHS) results in HIV viral nonsuppression via directly increasing depression, which then reduces adherence leading to nonsuppression; however, the dynamics between IHS and mental health are likely more complex. We sought to better understand IHS-mental health dynamics using data from a longitudinal clinical cohort of people with HIV (PWH) receiving healthcare across 10 US primary care clinics. Methods: Among 8,506 PWH who had ≥2 timepoints in which IHS, depression, and anxiety were measured, we examined changes over time in both two-state (i.e., impact of IHS on depression or anxiety and vice versa) and four-state combinations of depression-IHS (i.e., no depression or IHS, depression/no IHS, no depression/IHS, both depression/IHS) and anxiety-IHS. Transition probabilities between states and factors influencing transitions were identified using multistate Markov models. Results: The impact of IHS on the transition rates of mental health measures (i.e., depression, anxiety) and vice versa were almost the same, suggesting that each influences the other. Over 50% of PWH remained in the same IHS-depression or IHS-anxiety state. PWH with IHS had almost twice the rate of transitioning from no depression/anxiety to having depression/anxiety compared to PWH without IHS; with similar results for the depression or anxiety with no IHS to reporting IHS transition. Conclusions: We demonstrate that IHS and mental health dynamics are more complex than previously suspected and that the associations are bidirectional, which has implications for both future analyses and optimal management of these conditions among PWH.
Longitudinal Associations Between Internalized HIV Stigma and Lower HIV Antiretroviral Therapy Adherence Among People With HIV
Whitney, Bridget M. , Christopoulos, Katerina , Cachay, Edward R. , Keruly, Jeanne , Chander, Geetanjali , Johnson, Mallory O. , Yendewa, George A. , Saag, Michael S, Kitahata, Mari M. , Moore, R. D., Bamford, Laura , Fredericksen, Rob J. , Crane, Heidi M. , Drumright, Lydia N , Cachay, Edward, Drumright, Lydia N. , Delaney, Joseph A. , Crawford, Timothy N. , Christopoulos, Katerina A. , Mayer, Kenneth Hugh , Saag, Michael S. , Moore, Richard D. , Napravnik, Sonia

JAIDS Journal of Acquired Immune Deficiency Syndromes | November 6, 2025 | Volume: 101 | Issue: 3 | Pages: 249-256

10.1097/qai.0000000000003793 Get It

Background: Internalized HIV stigma (IHS) is associated with reductions in antiretroviral therapy (ART) adherence and HIV viremia mediated through depression. However, there is still a need to quantify the direct impact of IHS on ART adherence to inform interventions to improve medication adherence. Methods: The Center for AIDS Research Network of Integrated Clinical Systems is a longitudinal, US-based, multisite cohort of people with HIV who complete patient-reported outcome assessments as part of HIV-care visits. Patient-reported outcome data include IHS items, ART adherence, depression assessments, substance use, and other outcomes. We examined associations between IHS and ART adherence using generalized linear latent and mixed models with a nonparametric random effects intercept to accommodate repeated measures. Results were compared with analyses using generalized estimating equations and marginal structural models. Results: Among 13,119 people with HIV, the mean age was 47.4 years, 17.6% were women, and 59.3% were non-White. Across 33,139 observations, controlled for repeated measures on individuals, HIV medication adherence was reduced by 1.07% for every point increase in IHS after controlling for age, sex, ethnicity, geographic location, and substance use, and 0.58% when additionally adjusted for depression score. Marginal structural models and generalized estimating equations provided similar results. Conclusions: Our study demonstrates that IHS has a direct association with reductions in ART adherence, which could affect other comorbid health outcomes that are influenced by unsuppressed viremia over time. Developing a thorough understanding of the mechanisms through which IHS affects ART adherence is critical for developing interventions to mitigate IHS and improve health outcomes across the lifespan.